Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.

Follicular structures resembling germinal centres (GCs) that are characterized by follicular dendritic cell (FDC) networks have long been recognized in chronically inflamed tissues in autoimmune diseases, including the synovium of rheumatoid arthritis (RA). However, it is debated whether these ectop...

Full description

Bibliographic Details
Main Authors: Frances Humby, Michele Bombardieri, Antonio Manzo, Stephen Kelly, Mark C Blades, Bruce Kirkham, Jo Spencer, Costantino Pitzalis
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-01-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC2621263?pdf=render
id doaj-74b6ca0c890f4af9ad4725aa54bfecdd
record_format Article
spelling doaj-74b6ca0c890f4af9ad4725aa54bfecdd2020-11-25T01:33:52ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762009-01-0161e110.1371/journal.pmed.0060001Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.Frances HumbyMichele BombardieriAntonio ManzoStephen KellyMark C BladesBruce KirkhamJo SpencerCostantino PitzalisFollicular structures resembling germinal centres (GCs) that are characterized by follicular dendritic cell (FDC) networks have long been recognized in chronically inflamed tissues in autoimmune diseases, including the synovium of rheumatoid arthritis (RA). However, it is debated whether these ectopic structures promote autoimmunity and chronic inflammation driving the production of pathogenic autoantibodies. Anti-citrullinated protein/peptide antibodies (ACPA) are highly specific markers of RA, predict a poor prognosis, and have been suggested to be pathogenic. Therefore, the main study objectives were to determine whether ectopic lymphoid structures in RA synovium: (i) express activation-induced cytidine deaminase (AID), the enzyme required for somatic hypermutation and class-switch recombination (CSR) of Ig genes; (ii) support ongoing CSR and ACPA production; and (iii) remain functional in a RA/severe combined immunodeficiency (SCID) chimera model devoid of new immune cell influx into the synovium.Using immunohistochemistry (IHC) and quantitative Taqman real-time PCR (QT-PCR) in synovial tissue from 55 patients with RA, we demonstrated that FDC+ structures invariably expressed AID with a distribution resembling secondary lymphoid organs. Further, AID+/CD21+ follicular structures were surrounded by ACPA+/CD138+ plasma cells, as demonstrated by immune reactivity to citrullinated fibrinogen. Moreover, we identified a novel subset of synovial AID+/CD20+ B cells outside GCs resembling interfollicular large B cells. In order to gain direct functional evidence that AID+ structures support CSR and in situ manufacturing of class-switched ACPA, 34 SCID mice were transplanted with RA synovium and humanely killed at 4 wk for harvesting of transplants and sera. Persistent expression of AID and Igamma-Cmu circular transcripts (identifying ongoing IgM-IgG class-switching) was observed in synovial grafts expressing FDCs/CD21L. Furthermore, synovial mRNA levels of AID were closely associated with circulating human IgG ACPA in mouse sera. Finally, the survival and proliferation of functional B cell niches was associated with persistent overexpression of genes regulating ectopic lymphoneogenesis.Our demonstration that FDC+ follicular units invariably express AID and are surrounded by ACPA-producing plasma cells provides strong evidence that ectopic lymphoid structures in the RA synovium are functional and support autoantibody production. This concept is further confirmed by evidence of sustained AID expression, B cell proliferation, ongoing CSR, and production of human IgG ACPA from GC+ synovial tissue transplanted into SCID mice, independently of new B cell influx from the systemic circulation. These data identify AID as a potential therapeutic target in RA and suggest that survival of functional synovial B cell niches may profoundly influence chronic inflammation, autoimmunity, and response to B cell-depleting therapies.http://europepmc.org/articles/PMC2621263?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Frances Humby
Michele Bombardieri
Antonio Manzo
Stephen Kelly
Mark C Blades
Bruce Kirkham
Jo Spencer
Costantino Pitzalis
spellingShingle Frances Humby
Michele Bombardieri
Antonio Manzo
Stephen Kelly
Mark C Blades
Bruce Kirkham
Jo Spencer
Costantino Pitzalis
Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.
PLoS Medicine
author_facet Frances Humby
Michele Bombardieri
Antonio Manzo
Stephen Kelly
Mark C Blades
Bruce Kirkham
Jo Spencer
Costantino Pitzalis
author_sort Frances Humby
title Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.
title_short Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.
title_full Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.
title_fullStr Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.
title_full_unstemmed Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.
title_sort ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.
publisher Public Library of Science (PLoS)
series PLoS Medicine
issn 1549-1277
1549-1676
publishDate 2009-01-01
description Follicular structures resembling germinal centres (GCs) that are characterized by follicular dendritic cell (FDC) networks have long been recognized in chronically inflamed tissues in autoimmune diseases, including the synovium of rheumatoid arthritis (RA). However, it is debated whether these ectopic structures promote autoimmunity and chronic inflammation driving the production of pathogenic autoantibodies. Anti-citrullinated protein/peptide antibodies (ACPA) are highly specific markers of RA, predict a poor prognosis, and have been suggested to be pathogenic. Therefore, the main study objectives were to determine whether ectopic lymphoid structures in RA synovium: (i) express activation-induced cytidine deaminase (AID), the enzyme required for somatic hypermutation and class-switch recombination (CSR) of Ig genes; (ii) support ongoing CSR and ACPA production; and (iii) remain functional in a RA/severe combined immunodeficiency (SCID) chimera model devoid of new immune cell influx into the synovium.Using immunohistochemistry (IHC) and quantitative Taqman real-time PCR (QT-PCR) in synovial tissue from 55 patients with RA, we demonstrated that FDC+ structures invariably expressed AID with a distribution resembling secondary lymphoid organs. Further, AID+/CD21+ follicular structures were surrounded by ACPA+/CD138+ plasma cells, as demonstrated by immune reactivity to citrullinated fibrinogen. Moreover, we identified a novel subset of synovial AID+/CD20+ B cells outside GCs resembling interfollicular large B cells. In order to gain direct functional evidence that AID+ structures support CSR and in situ manufacturing of class-switched ACPA, 34 SCID mice were transplanted with RA synovium and humanely killed at 4 wk for harvesting of transplants and sera. Persistent expression of AID and Igamma-Cmu circular transcripts (identifying ongoing IgM-IgG class-switching) was observed in synovial grafts expressing FDCs/CD21L. Furthermore, synovial mRNA levels of AID were closely associated with circulating human IgG ACPA in mouse sera. Finally, the survival and proliferation of functional B cell niches was associated with persistent overexpression of genes regulating ectopic lymphoneogenesis.Our demonstration that FDC+ follicular units invariably express AID and are surrounded by ACPA-producing plasma cells provides strong evidence that ectopic lymphoid structures in the RA synovium are functional and support autoantibody production. This concept is further confirmed by evidence of sustained AID expression, B cell proliferation, ongoing CSR, and production of human IgG ACPA from GC+ synovial tissue transplanted into SCID mice, independently of new B cell influx from the systemic circulation. These data identify AID as a potential therapeutic target in RA and suggest that survival of functional synovial B cell niches may profoundly influence chronic inflammation, autoimmunity, and response to B cell-depleting therapies.
url http://europepmc.org/articles/PMC2621263?pdf=render
work_keys_str_mv AT franceshumby ectopiclymphoidstructuressupportongoingproductionofclassswitchedautoantibodiesinrheumatoidsynovium
AT michelebombardieri ectopiclymphoidstructuressupportongoingproductionofclassswitchedautoantibodiesinrheumatoidsynovium
AT antoniomanzo ectopiclymphoidstructuressupportongoingproductionofclassswitchedautoantibodiesinrheumatoidsynovium
AT stephenkelly ectopiclymphoidstructuressupportongoingproductionofclassswitchedautoantibodiesinrheumatoidsynovium
AT markcblades ectopiclymphoidstructuressupportongoingproductionofclassswitchedautoantibodiesinrheumatoidsynovium
AT brucekirkham ectopiclymphoidstructuressupportongoingproductionofclassswitchedautoantibodiesinrheumatoidsynovium
AT jospencer ectopiclymphoidstructuressupportongoingproductionofclassswitchedautoantibodiesinrheumatoidsynovium
AT costantinopitzalis ectopiclymphoidstructuressupportongoingproductionofclassswitchedautoantibodiesinrheumatoidsynovium
_version_ 1725075235878731776